Clinical Trial Update: Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial comparing methylphenidate to risperidone for children/adolescents with ADHD and disruptive disorders; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Conduct Disorder
• Oppositional Defiant Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Sheba Medical Center | Conditions: Attention Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder | Phase 4 | Status: TERMINATED